Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 500,000 shares at $20.03 ($10.0M) on 2013-09-16, disclosed to the SEC on 2013-09-18.
Open-market sale of $10.0M SGNT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGNT | SELL | 2014-10-08 | $505K | — | Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |